19-13207858-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001127222.2(CACNA1A):c.6970_6975dupCAGCAG(p.Gln2324_Gln2325dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 3 hom., cov: 0)
Exomes 𝑓: 0.0024 ( 23 hom. )
Consequence
CACNA1A
NM_001127222.2 conservative_inframe_insertion
NM_001127222.2 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Publications
10 publications found
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
- episodic ataxia type 2Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- developmental and epileptic encephalopathy, 42Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- migraine, familial hemiplegic, 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- spinocerebellar ataxia type 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- benign paroxysmal torticollis of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial or sporadic hemiplegic migraineInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 19-13207858-C-CCTGCTG is Benign according to our data. Variant chr19-13207858-C-CCTGCTG is described in ClinVar as [Likely_benign]. Clinvar id is 1285153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00273 (404/147904) while in subpopulation EAS AF = 0.0139 (67/4816). AF 95% confidence interval is 0.0112. There are 3 homozygotes in GnomAd4. There are 225 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High AC in GnomAd4 at 404 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.6970_6975dupCAGCAG | p.Gln2324_Gln2325dup | conservative_inframe_insertion | Exon 47 of 47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6988_6993dupCAGCAG | p.Gln2330_Gln2331dup | conservative_inframe_insertion | Exon 48 of 48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.6976_6981dupCAGCAG | p.Gln2326_Gln2327dup | conservative_inframe_insertion | Exon 47 of 47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.6973_6978dupCAGCAG | p.Gln2325_Gln2326dup | conservative_inframe_insertion | Exon 47 of 47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.6973_6978dupCAGCAG | p.Gln2325_Gln2326dup | conservative_inframe_insertion | Exon 47 of 47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.6937_6942dupCAGCAG | p.Gln2313_Gln2314dup | conservative_inframe_insertion | Exon 46 of 46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.6832_6837dupCAGCAG | p.Gln2278_Gln2279dup | conservative_inframe_insertion | Exon 46 of 46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636768.2 | n.*1231_*1236dupCAGCAG | non_coding_transcript_exon_variant | Exon 45 of 45 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000713789.1 | n.*2149_*2154dupCAGCAG | non_coding_transcript_exon_variant | Exon 47 of 47 | ENSP00000519091.1 | |||||
CACNA1A | ENST00000636389.1 | c.*56_*61dupCAGCAG | 3_prime_UTR_variant | Exon 47 of 47 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000637432.1 | c.*182_*187dupCAGCAG | 3_prime_UTR_variant | Exon 48 of 48 | 5 | ENSP00000490617.1 | ||||
CACNA1A | ENST00000635895.1 | c.*182_*187dupCAGCAG | 3_prime_UTR_variant | Exon 47 of 47 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009.2 | c.*182_*187dupCAGCAG | 3_prime_UTR_variant | Exon 47 of 47 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000637276.1 | c.*182_*187dupCAGCAG | 3_prime_UTR_variant | Exon 46 of 46 | 5 | ENSP00000489777.1 | ||||
CACNA1A | ENST00000636768.2 | n.*1231_*1236dupCAGCAG | 3_prime_UTR_variant | Exon 45 of 45 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000713789.1 | n.*2149_*2154dupCAGCAG | 3_prime_UTR_variant | Exon 47 of 47 | ENSP00000519091.1 | |||||
CACNA1A | ENST00000636549.1 | c.*182_*187dupCAGCAG | downstream_gene_variant | 5 | ENSP00000490578.1 | |||||
CACNA1A | ENST00000637927.1 | c.*182_*187dupCAGCAG | downstream_gene_variant | 5 | ENSP00000489715.1 |
Frequencies
GnomAD3 genomes AF: 0.00273 AC: 404AN: 147802Hom.: 3 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
404
AN:
147802
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00527 AC: 274AN: 52038 AF XY: 0.00509 show subpopulations
GnomAD2 exomes
AF:
AC:
274
AN:
52038
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00244 AC: 3128AN: 1283858Hom.: 23 Cov.: 0 AF XY: 0.00256 AC XY: 1615AN XY: 631904 show subpopulations
GnomAD4 exome
AF:
AC:
3128
AN:
1283858
Hom.:
Cov.:
0
AF XY:
AC XY:
1615
AN XY:
631904
show subpopulations
African (AFR)
AF:
AC:
72
AN:
24930
American (AMR)
AF:
AC:
114
AN:
24096
Ashkenazi Jewish (ASJ)
AF:
AC:
30
AN:
21718
East Asian (EAS)
AF:
AC:
303
AN:
29576
South Asian (SAS)
AF:
AC:
445
AN:
65600
European-Finnish (FIN)
AF:
AC:
72
AN:
33418
Middle Eastern (MID)
AF:
AC:
20
AN:
3752
European-Non Finnish (NFE)
AF:
AC:
1893
AN:
1027626
Other (OTH)
AF:
AC:
179
AN:
53142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
132
263
395
526
658
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00273 AC: 404AN: 147904Hom.: 3 Cov.: 0 AF XY: 0.00312 AC XY: 225AN XY: 72002 show subpopulations
GnomAD4 genome
AF:
AC:
404
AN:
147904
Hom.:
Cov.:
0
AF XY:
AC XY:
225
AN XY:
72002
show subpopulations
African (AFR)
AF:
AC:
101
AN:
40206
American (AMR)
AF:
AC:
55
AN:
14968
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3436
East Asian (EAS)
AF:
AC:
67
AN:
4816
South Asian (SAS)
AF:
AC:
32
AN:
4704
European-Finnish (FIN)
AF:
AC:
15
AN:
9952
Middle Eastern (MID)
AF:
AC:
7
AN:
276
European-Non Finnish (NFE)
AF:
AC:
118
AN:
66606
Other (OTH)
AF:
AC:
6
AN:
2044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
CACNA1A: BS1, BS2 -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Spinocerebellar ataxia type 6;C1720416:Episodic ataxia type 2;C1832884:Migraine, familial hemiplegic, 1;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Nov 18, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.